• Explore /
  • Poster
  • / CD19/CD20 bispecific chimeric antigen receptor (CAR) in naïve/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma.

CD19/CD20 bispecific chimeric antigen receptor (CAR) in naïve/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma.

Abstract Poster

Authors

null

Sarah Marie Larson

University of California, Los Angeles, Los Angeles, CA

Sarah Marie Larson , Christopher Walthers , Brenda Ji , Sanaz N. Ghafouri , Jacob Naparstek , Jacqueline Trent , Caitlin Harris , Mobina Khericha Gandhi , Thomas Schweppe , Martin S. Auerbach , Jonathan W. Said , Karla Nawaly , Monica Diane Mead , Sven De Vos , Patricia Young , Caspian Oliai , Gary J. Schiller , John Timmerman , Antoni Ribas , Yvonne Y Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

Cellular Immmunotherapy

Clinical Trial Registration Number

NCT04007029

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 2543)

DOI

10.1200/JCO.2022.40.16_suppl.2543

Abstract #

2543

Poster Bd #

198

Abstract Disclosures

Similar Posters

First Author: Zhongwei Zhao

First Author: Alison R. Sehgal

First Author: Bo Zhai

First Author: Samer Ali Srour